FundedAndHiringPulse / compare

Limonite Series of Loan LLC vs Palimpsest Bio Corp.: FundedAndHiringPulse comparison

Limonite Series of Loan LLC's offering of 3,350,000 is 3.4x Palimpsest Bio Corp.'s 1,000,000 (34th percentile). Limonite Series of Loan LLC is dated 2026-11-02; Palimpsest Bio Corp. 2026-10-30.

Data as of · Compiled by Zalwin from SEC EDGAR Form D via FormDPulse (operating companies only, no individuals)

Both records plus every comparable NV record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe

How does Limonite Series of Loan LLC compare to Palimpsest Bio Corp.?

FieldLimonite Series of Loan LLCPalimpsest Bio Corp.
CompanyLimonite Series of Loan LLCPalimpsest Bio Corp.
LocationLas Vegas, NVLas Vegas, NV
IndustryResidentialBiotechnology
Likely hiringOtherHealthcare and life sciences (clinical, R&D)
Offering$3,350,000$1,000,000
Sold so far$3,350,000$172,000
Filed2026-11-02 (3 days ago)2026-10-30 (6 days ago)
Incorporated20262026
Revenue rangeNo RevenuesNo Revenues
Next stepsFind the company website, then run /jobpostingschemapulse on its careers page or /prospectteardown on its home page.Find the company website, then run /jobpostingschemapulse on its careers page or /prospectteardown on its home page.
amount percentile34th6th
Scaling Signal Score70/10075/100
Peer rank and all 12 NV records (CSV) 🔒 Click to unlock →
Official source URLs for every peer record 🔒 Click to unlock →

Official records: Limonite Series of Loan LLC · Palimpsest Bio Corp.

Get new funded companies in your niche every week

FundedAndHiringPulse can email you new filers matching your states, hiring classes and raise sizes.

See plans

Built from SEC Form D filings, which report an offering, not a hiring plan; "likely to hire" is our classification from industry and raise size, not a statement by the company. Filings can be amended or withdrawn; confirm on SEC EDGAR. Companies only; individuals named in filings are not included. Not a consumer report and may not be used for FCRA purposes. Not investment advice.

Often used together